共 155 条
[1]
Zhai Z(2020)Prevention Treatment of VTEAwC-ICSG: Prevention and treatment of venous Thromboembolism Associated with Coronavirus Disease 2019 infection: a Consensus Statement before guidelines Thromb Haemost 120 937-48
[2]
Li C(2020)Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans Lancet Respir Med 8 681-6
[3]
Chen Y(2020)Incidence of venous thromboembolism in hospitalized patients with COVID-19 J Thromb Haemost 18 1995-2002
[4]
Gerotziafas G(2020)Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID) Thromb Res 196 359-66
[5]
Zhang Z(2020)SARS-CoV-2 and viral sepsis: observations and hypotheses Lancet 395 1517-20
[6]
Wan J(2020)Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan Circulation 142 181-3
[7]
Liu P(2021)A systematic review and a Meta-analysis comparing prophylactic and therapeutic low Molecular Weight Heparins for Mortality reduction in 32,688 COVID-19 patients Front Pharmacol 12 698008-4
[8]
Elalamy I(2020)Association of Treatment Dose Anticoagulation with In-Hospital survival among hospitalized patients with COVID-19 J Am Coll Cardiol 76 122-89
[9]
Wang C(2021)Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial BMJ 375 n2400-77
[10]
Fox SE(2021)Therapeutic anticoagulation with heparin in critically ill patients with Covid-19 N Engl J Med 385 777-56